IL17A and nephritis: Chu et al. reported that intravenous administration of murine recombinant IL-38 into specific kinds of mice can ameliorate skin inflammation and nephritis in mice with SLE, probably via suppressing the secretion of inflammatory cytokines such as IL-17 and IL-22.